tiprankstipranks
Trending News
More News >
Oruka Therapeutics (ORKA)
NASDAQ:ORKA
US Market

Oruka Therapeutics (ORKA) Financial Statements

Compare
606 Followers

Oruka Therapeutics Financial Overview

Oruka Therapeutics's market cap is currently $393.13M. The company's EPS TTM is $-6.426; its P/E ratio is ―; Oruka Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ -27.00K$ -91.00K$ -93.00K
Operating Income$ -88.12M$ -19.34M$ -9.77M
EBITDA$ -82.23M$ -19.23M$ -9.64M
Net Income$ -83.72M$ -19.32M$ -9.74M
Balance Sheet
Cash & Short-Term Investments$ 375.65M$ 53.36M$ 49.07M
Total Assets$ 396.02M$ 54.92M$ 50.43M
Total Debt$ 968.00K$ 483.00K$ 450.00K
Net Debt$ -60.61M$ -52.88M$ -48.62M
Total Liabilities$ 13.80M$ 3.88M$ 3.91M
Stockholders' Equity$ 382.22M$ 51.04M$ 46.52M
Cash Flow
Free Cash Flow$ -58.03M$ -18.80M$ -7.74M
Operating Cash Flow$ -57.84M$ -18.76M$ -7.72M
Investing Cash Flow$ -330.13M$ -43.00K$ -19.00K
Financing Cash Flow$ 449.54M$ 23.09M$ 48.45M
Currency in USD

Oruka Therapeutics Earnings and Revenue History

Oruka Therapeutics Debt to Assets

Oruka Therapeutics Cash Flow

Oruka Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis